163 related articles for article (PubMed ID: 32277846)
1. CD4
Freiwald T; Büttner S; Cheru NT; Avaniadi D; Martin SS; Stephan C; Pliquett RU; Asbe-Vollkopf A; Schüttfort G; Jacobi V; Herrmann E; Geiger H; Hauser IA
Clin Transplant; 2020 Sep; 34(9):e13877. PubMed ID: 32277846
[TBL] [Abstract][Full Text] [Related]
2. Impaired thymic function and CD4+ T lymphopenia, but not mannose-binding lectin deficiency, are risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients.
Schürmann M; Schürmann D; Schindler R; Meisel C; Liman P; Kruse J; Enghard P; König J; Schmidt D; Reinke P; Nickel P
Transpl Immunol; 2013 Jun; 28(4):159-63. PubMed ID: 23684946
[TBL] [Abstract][Full Text] [Related]
3. Identification of Predictive Markers and Outcomes of Late-onset Pneumocystis jirovecii Pneumonia in Kidney Transplant Recipients.
Kaminski H; Belliere J; Burguet L; Del Bello A; Taton B; Poirot-Mazères S; Accoceberry I; Delhaes L; Visentin J; Gregori M; Iriart X; Charpentier E; Couzi L; Kamar N; Merville P
Clin Infect Dis; 2021 Oct; 73(7):e1456-e1463. PubMed ID: 33095856
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for Pneumocystis pneumonia with acute respiratory failure among kidney transplant recipients.
Lee HJ; Kwon HW; Baek JK; Park CH; Seo HK; Hong SK
BMC Nephrol; 2023 Feb; 24(1):31. PubMed ID: 36759777
[TBL] [Abstract][Full Text] [Related]
5. Lymphopenia is associated with late onset Pneumocystis jirovecii pneumonia in solid organ transplantation.
Werbel WA; Ison MG; Angarone MP; Yang A; Stosor V
Transpl Infect Dis; 2018 Jun; 20(3):e12876. PubMed ID: 29512868
[TBL] [Abstract][Full Text] [Related]
6. Impact of Pneumocystis jirovecii pneumonia on kidney transplant outcome.
Kim JE; Han A; Lee H; Ha J; Kim YS; Han SS
BMC Nephrol; 2019 Jun; 20(1):212. PubMed ID: 31182046
[TBL] [Abstract][Full Text] [Related]
7. CMV Infection and Lymphopenia: Warning Markers of
Eberl I; Binquet C; Guilloteau A; Legendre M; Dalle F; Piroth L; Tinel C; Blot M
Transpl Int; 2024; 37():12192. PubMed ID: 38328616
[No Abstract] [Full Text] [Related]
8. Late-onset Pneumocystis jirovecii pneumonia in solid organ transplant recipients.
Perez-Ordoño L; Hoyo I; Sanclemente G; Ricart MJ; Cofan F; Perez-Villa F; de la Bellacasa JP; Moreno A; Cervera C
Transpl Infect Dis; 2014 Apr; 16(2):324-8. PubMed ID: 24456244
[TBL] [Abstract][Full Text] [Related]
9. Risk of Pneumocystis jiroveci pneumonia in patients long after renal transplantation.
Struijk GH; Gijsen AF; Yong SL; Zwinderman AH; Geerlings SE; Lettinga KD; van Donselaar-van der Pant KA; ten Berge IJ; Bemelman FJ
Nephrol Dial Transplant; 2011 Oct; 26(10):3391-8. PubMed ID: 21385859
[TBL] [Abstract][Full Text] [Related]
10. Six-month risk of Pneumocystis pneumonia following acute cellular rejection: A case-control study in solid organ transplant recipients.
Hosseini-Moghaddam SM; Shokoohi M; Singh G; Nagpal AD; Jevnikar AM
Clin Transplant; 2021 Jul; 35(7):e14322. PubMed ID: 33882151
[TBL] [Abstract][Full Text] [Related]
11. Successful management of concurrent COVID-19 and Pneumocystis Jirovecii Pneumonia in kidney transplant recipients: a case series.
Li G; Ji D; Chang Y; Tang Z; Cheng D
BMC Pulm Med; 2023 Nov; 23(1):458. PubMed ID: 37990199
[TBL] [Abstract][Full Text] [Related]
12. The Changing Landscape of Pneumocystis Jiroveci Infection in Kidney Transplant Recipients: Single-Center Experience of Late-Onset Pneumocystis Pneumonia.
Marinaki S; Vallianou K; Melexopoulou C; Lionaki S; Darema M; Lambrou P; Boletis I
Transplant Proc; 2021 Jun; 53(5):1576-1582. PubMed ID: 33962778
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and outcomes of Pneumocystis pneumonia in solid organ transplant recipients: Impact of posttransplant lymphoproliferative disorder.
Yetmar ZA; Duffy D; Smith BH; Vikram HR; Brumble L; Limper AH; Beam E
Clin Transplant; 2023 Sep; 37(9):e15021. PubMed ID: 37195184
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6-month trimethoprim-sulfamethoxazole prophylaxis: A case-control study.
Park SY; Jung JH; Kwon H; Shin S; Kim YH; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH; Han DJ
Transpl Infect Dis; 2020 Apr; 22(2):e13245. PubMed ID: 31943590
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for late-onset Pneumocystis jirovecii pneumonia in liver transplant recipients.
Min EK; Lee J; Jeong SJ; Kim DG; Yim SH; Choi MC; Joo DJ; Kim MS; Lee JG
Int J Infect Dis; 2023 Jun; 131():166-172. PubMed ID: 37044172
[TBL] [Abstract][Full Text] [Related]
16. Pneumocystis jiroveci pneumonia (PCP) in HIV-1-negative patients: a retrospective study 2002-2004.
Overgaard UM; Helweg-Larsen J
Scand J Infect Dis; 2007; 39(6-7):589-95. PubMed ID: 17577823
[TBL] [Abstract][Full Text] [Related]
17. Lessons learned from a pneumocystis pneumonia outbreak at a Scottish renal transplant centre.
McClarey A; Phelan P; O'Shea D; Henderson L; Gunson R; Laurenson IF
J Hosp Infect; 2019 Jul; 102(3):311-316. PubMed ID: 30802526
[TBL] [Abstract][Full Text] [Related]
18. Pneumocystis jirovecii pneumonia in renal transplant recipients: a national center experience.
Borstnar S; Lindic J; Tomazic J; Kandus A; Pikelj A; Prah J; Skvarc M; Godnov U; Kovac D
Transplant Proc; 2013 May; 45(4):1614-7. PubMed ID: 23726632
[TBL] [Abstract][Full Text] [Related]
19. Peripheral blood CD4 + T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection.
Mansharamani NG; Balachandran D; Vernovsky I; Garland R; Koziel H
Chest; 2000 Sep; 118(3):712-20. PubMed ID: 10988193
[TBL] [Abstract][Full Text] [Related]
20. Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years.
Schmidt JJ; Lueck C; Ziesing S; Stoll M; Haller H; Gottlieb J; Eder M; Welte T; Hoeper MM; Scherag A; David S
Crit Care; 2018 Nov; 22(1):307. PubMed ID: 30454031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
